Clinical Trial Update: Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia [NA]

View source ↗

Summary

This clinical trial investigates whether circulating tumor DNA after six months of treatment can predict outcomes in patients with Waldenström macroglobulinemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Waldenstrom's Disease, Waldenstrom Macroglobulinemia | NA | Status: RECRUITING